Intrommune Therapeutics, Inc., a clinical-stage biotechnology company committed to developing a patient-friendly treatment platform for people with peanut and other food allergies, ...

Chicken is always a smart summer pick, but it can still feel fresh. These recipes give you dependable ideas for cookouts, ...

One year on from the presentation of the concept, Peugeot’s venerated GTi label has returned and gone electric with the ...

Brazilian officials have announced a significant drop in deforestation rates. Brazilian officials on Thursday thus pushed ...

San Francisco's AI economy is mostly being defined by the companies spending the most. Foundation model labs raise billions, ...

Diabetology Limited (Jersey) poster presentation ( 1724-P at the ADA 86th Scientific Session, New Orleans, reporting first human data from Oraglutide™ — small capsule intestinally-released oral ...

MSI has unveiled its latest PC component lineup at Computex 2026, showcasing high-performance AM5 motherboards with AMD EXPO ...

NEWARK, CA / ACCESS Newswire / June 1, 2026 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced that four abstracts highlighting rusfertide in polycythemia vera (PV) will ...

Beep beep – boop. This could be how we’ll all talk one day if Google’s predictions about humanity’s future come true. Well, kind of. Metro attended the tech giant’s annual developer conference, Google ...

Abstract: Distinguishing attention deficit/hyperactivity disorder (ADHD) presentations, such as predominantly inattentive (ADHD-I) and hyperactive/impulsive (ADHD-HI), is clinically important for ...

– Alterity’s novel imaging and biomarker approach positions the Company at the forefront of clinical research in MSA – – End-of-Phase 2 FDA Meeting on track for mid-2026 to confirm path forward for ...